X

Trial Profile

A proof-of-concept study of SB-751689 [ronacaleret] in men and post-menopausal women with a fractured distal radius.

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 05 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ronacaleret (Primary)
Indications Fracture
Focus Proof of concept; Therapeutic Use
Sponsors GlaxoSmithKline; GSK

Most Recent Events

08 Apr 2022 This trial has been completed in Spain (Global end date: 20-11-2008), according to European Clinical Trials Database record
14 Apr 2010 Additional trial location [China] identified as reported by ClinicalTrials.gov.
11 Sep 2009 Results presented at the 31st Annual Meeting of the American Society for Bone and Mineral Research.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com